ByHeart has acquired a manufacturing facility in Allerton, Iowa, to enhance its production capacity and meet the growing demand for high-quality infant formula.
Target Information
ByHeart, a next-generation baby nutrition company founded in 2016 and headquartered in New York City, is dedicated to empowering parents with innovative feeding solutions. The company has made significant strides in the infant formula market, providing products that adhere to the highest nutritional standards and are free from additives like corn syrup and soy. Its unique clinical research supports the effectiveness of its infant formula, distinguished by a patented protein blend that closely resembles breast milk.
As of January 25, 2023, ByHeart has announced the acquisition of a manufacturing facility in Allerton, Iowa, from DairiConcepts, aiming to further enhance its production capabilities. This acquisition, combined with its existing facilities, positions ByHeart to meet the nutritional needs of approximately 500,000 infants annually.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The infant formula industry in the United States has been historically dominated by three major players, controlling 90% of the market. This has led to a lack of competition and innovation within the
Similar Deals
HALO Dream Inc. → Baby Merlin
2025
Altas Partners → Redwood Services
2025
Crown Laboratories, Inc. → Revance Therapeutics, Inc.
2025
Entrepreneurial Equity Partners → Bil-Jac Foods
2025
Northleaf Capital Partners and AVALT → WASH Multifamily Holdings Inc.
2025
ByHeart
invested in
DairiConcepts Allerton Facility
in 2023
in a Other Private Equity deal